US$ 29.50
semaglutide after breast cancer GLP-1 use linked to lower incidence in large cohort study How GLP-1 Drugs Helped Me
Description
Food and Drug Administration (FDA) in May 2022 for the treatment of type 2 diabetes [1]

In the UK, NICE Technology Appraisal 875 restricts NHS access to specialist weight management services, typically for people with BMI 35 kg/m with at least one weight-related comorbidity (with adjusted thresholds for certain ethnic groups)

The decision to start, continue or stop a GLP-1 is highly individual and best made with a multidisciplinary team familiar with GLP-1 and eating disorders
If the outage ends within 4 hours, your medication is almost certainly fine
